Insights into Channelopathies and Sport: The Genotype-Positive/Phenotype-Negative Athlete from Molecular Diagnosis to Management
Channelopathies, diseases with ion channel perturbations, are a major cause of sudden cardiac death in athletes. Advances in genetic testing have identified a growing population of athletes carrying (likely) pathogenic variants in cardiac ion channel genes who remain phenotypically silent. These genotype-positive/phenotype-negative (G+/P−) individuals present a distinct clinical challenge. Standard preparticipation screening, designed around phenotypic findings, provides little guidance for their management. A critical gap exists in providing prognostic guidance based on the involved gene, specific variants, and its molecular consequences. Beyond a critical review of existing literature, we provide a mechanistically anchored framework for variant-specific arrhythmic risk stratification across the major channelopathy genes. For each gene, we translate molecular pathophysiology into clinically actionable risk profiles and examine how exercise-specific triggers, including adrenergic surge, electrolyte shifts, and sympathovagal imbalance, interact with the underlying molecular substrate to modulate arrhythmic vulnerability. Standard diagnostic tools ranging from electro- and echocardiography, exercise stress testing, and pharmacological provocation to emerging modalities such as electroanatomic mapping and magnetocardiography are evaluated for their capacity to unmask subclinical disease and refine sports eligibility decisions. The case for an interdisciplinary sports-cardio-genetic board is made alongside a call for international collaborative registries, as existing evidence in G+/P− athletes is largely absent. The integration of artificial intelligence and telemonitoring into longitudinal athletic surveillance is discussed as a pragmatic strategy for early phenotype detection. Ultimately, guidance for the G+/P− athlete rests on a thorough understanding of the causative genetic variant and its pathophysiological consequences.
Authors
- Flavio D’Ascenzi (ORCID: https://orcid.org/0000-0002-0947-6836)
- David Niederseer (ORCID: https://orcid.org/0000-0003-3089-1222)
- Ardan Muammer Saguner (ORCID: https://orcid.org/0000-0003-1896-0803)
- Satyam Sarma (ORCID: https://orcid.org/0000-0002-0628-4919)
- Juliane Winkelmann (ORCID: https://orcid.org/0000-0002-3074-599X)
- Isabel Diebold (ORCID: https://orcid.org/0000-0002-1753-563X)
- Manuel Rattka (ORCID: https://orcid.org/0000-0002-3269-3871)
- Ulrike Schön
- Franziska Hahn (ORCID: https://orcid.org/0009-0000-2214-5487)
- Martin Halle (ORCID: https://orcid.org/0000-0003-3065-530X)
- Silvia Castelletti (ORCID: https://orcid.org/0000-0001-9693-4083)
- Simon Wernhart (ORCID: https://orcid.org/0000-0001-6732-0939)
- Eimo Martens (ORCID: https://orcid.org/0000-0002-5801-0901)
- Annette Wacker‐Gussmann (ORCID: https://orcid.org/0000-0001-5143-5029)
- Karl‐Ludwig Laugwitz (ORCID: https://orcid.org/0000-0003-4948-4846)
Institutions
- University of Siena (IT)
- University of Zurich (CH)
- Texas Health Dallas (US)
- Helmholtz Zentrum München (DE)
- University Hospital of Zurich (CH)
- Munich Cluster for Systems Neurology (DE)
- Medical Genetics Center (DE)
- CK-CARE (CH)
- Ospedale Santa Maria della Misericordia di Udine (IT)
- German Centre for Cardiovascular Research (DE)
- ERN GUARD-Heart (NL)
- Institute for Exercise and Environmental Medicine (US)
- Deutsches Herzzentrum München (DE)
- Hochgebirgsklinik Davos (CH)
- Institut für Humangenetik (DE)
- Technical University of Munich (DE)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Sports Medicine
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1007/s40279-026-02584-4
- Primary Topic
- Cardiovascular Effects of Exercise
- Type
- article
- Field-Weighted Citation Impact
- 0.00